Going forward, patients undergoing surgery for recurrent brain tumors will benefit from GT Medical’s GammaTile™ Therapy, which helps prevent additional tumor recurrence. GT Medical Technology recently received 510(k) clearance from the FDA, which allows the technology to reach the market. GT Medical was a 2018 Rosenman Innovator.

Read coverage on MassDevice